# Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

> **NCT00993720** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hvidovre University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Liraglutide
- **OTHER:** continuous insulin therapy

## Key facts

- **NCT ID:** NCT00993720
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993720, "Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00993720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*